Low Blood Absolute CD4 Counts Is Associated with Inferior Progression Free Survival in Diffuse Large B-Cell Lymphoma Independent of Age and IPI

被引：0
|
作者：
Al-Saleem, Tahseen I. [1 ]
Dulaimi, Essel [1 ]
Millenson, Michael M. [1 ]
Smith, Mitchell R. [2 ]
Judd, Julia [1 ]
Li, Tianyu [1 ]
Borghaei, Hossein [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CD4-positive diffuse large B-cell lymphoma: a variant
    Akkaya, B.
    Yilmaz, D. B.
    Ulas, T.
    Salim, O.
    VIRCHOWS ARCHIV, 2018, 473 : S271 - S272
  • [42] Absolute peripheral CD4+T-cell count predicts prognosis of patients with diffuse large B-cell lymphoma
    Kusano, Yoshiharu
    Terui, Yasuhito
    CANCER SCIENCE, 2018, 109 : 493 - 493
  • [43] Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma
    Porrata, Luis F.
    Ristow, Kay M.
    Colgan, Joseph P.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Inwards, David James
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Nowakowski, Grzegorz S.
    Thompson, Carrie A.
    Markovic, Svetomir N.
    BLOOD, 2011, 118 (21) : 1560 - 1561
  • [44] Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma
    Wei, Xiaolei
    Wei, Yongqiang
    Huang, Weimin
    Song, Jialin
    Wei, Qi
    Feng, Ru
    BLOOD, 2017, 130
  • [45] Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma
    Mubarak M. Al-Mansour
    Saif A. Alghamdi
    Musab A. Alsubaie
    Abdullah A. Alesa
    Muhammad A. Khan
    Infectious Agents and Cancer, 13
  • [46] Progression Free Survival at 24 Months in Patients with Diffuse Large B-Cell Lymphoma, an Argentinian Retrospective Cohort Study
    Warley, Fernando
    Cristaldo, Nancy
    Colucci, Giuliana
    Otero, Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S290 - S291
  • [47] Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma
    Al-Mansour, Mubarak M.
    Alghamdi, Saif A.
    Alsubaie, Musab A.
    Alesa, Abdullah A.
    Khan, Muhammad A.
    INFECTIOUS AGENTS AND CANCER, 2018, 13
  • [48] The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Aoki, Kazunari
    Tabata, Sumie
    Yonetani, Noboru
    Matsushita, Akiko
    Ishikawa, Takayuki
    ACTA HAEMATOLOGICA, 2013, 130 (04) : 242 - 246
  • [49] External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival
    Warnnissorn, Naree
    Kanitsap, Nonglak
    Niparuck, Pimjai
    Boonsakan, Paisarn
    Kulalert, Prapasri
    Limvorapitak, Wasithep
    Bhoopat, Lantarima
    Saengboon, Supawee
    Chantrathammachart, Pichika
    Puavilai, Teeraya
    Chuncharunee, Suporn
    HEMATOLOGY, 2022, 27 (01) : 1237 - 1245
  • [50] HIGH-DOSE METHOTREXATE CONSOLIDATION IN POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA IS ASSOCIATED WITH IMPROVED PROGRESSION FREE SURVIVAL
    Gilbertson, M.
    Shortt, J.
    Grigoriadis, G.
    Patil, S.
    Gregory, G.
    Wang, Z.
    Kumar, B.
    Opat, S. S.
    HAEMATOLOGICA, 2014, 99 : 705 - 706
12345